Clinical Trial Update: n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial Fibrillation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating n-3 polyunsaturated fatty acids for the prevention of atrial fibrillation has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED | Results posted: 2011-07-21